Showing results (451-460 of 559) with videos related to

Sort By:
Pageof 56
Oral Diseases|November 21, 2012
Arecoline-stimulated placenta growth factor production in gingival epithelial cells: modulation by curcuminS-J Cheng, H-H Ko, S-L Cheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokersF R Khuri, J S Lee, S M Lippman, et al.
Psychopharmacology|September 5, 2020
Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCDD M Eagle, C Schepisi, S Chugh, et al.
Oral Oncology|November 30, 2002
Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytesS H Kok, C Y Hong, M Y P Kuo, et al.
Anaerobe|February 26, 2022
Genetic and phenotypic characteristics of Clostridium (Clostridioides) difficile from canine, bovine, and pediatric populationsL E Redding, V Tu, A Abbas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinomaR S Herbst, S Yano, H Kuniyasu, et al.
Respiratory Medicine|May 4, 2010
Airway eosinophilia in remission and progression of asthma: accumulation with a fast decline of FEV(1)M Broekema, F Volbeda, W Timens, et al.
Cancer|April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinomaD M Shin, F R Khuri, B S Glisson, et al.
Melanoma Research|June 4, 1998
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanomaA C Buzaid, F Ali-Osman, N Akande, et al.
Biopharmaceutics & Drug Disposition|August 1, 1995
Pharmacokinetics and antitumour activity of a new anthracycline, DA-125, after intravenous administration to subcutaneously implanted Lewis-lung-carcinoma-bearing miceS D Lee, J B Park, W I Lee, et al.
Pageof 56